Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer

This phase 1 study evaluates the safety, clinical activity, and biomarkers associated with the use of single-agent atezolizumab in women with metastatic triple-negative breast cancer.

https://ift.tt/2Mv0z1f